High SChLAP1 expression is significantly associated with a higher risk of lethal PCa and PCa-specific death independent of age at diagnosis, GS, and pathologic stageHigh SChLAP1 expression is associated with lethal PCa among patients with non-advanced clinical tumor stage, but not among patients with advanced clinical tumor stage. This evidence concerns the gene SCHLAP1 and posterior cortical atrophy.